Bayer cuts Monsanto deal value to $63.5 billion on revised debt

FRANKFURT (Reuters) - German drugmaker Bayer has cut the value of its takeover of Monsanto by $2.5 billion, which combined with windfalls from asset sales means it may have to raise less than expected from shareholders.